Wednesday, February 11, 2026

137 Degrees® Partners with Butterbear for “Nong Noey Gives Luck, Gifting Lucky Ang Paos” to Celebrate Chinese New Year 2026: Boosting Fortune, Health, and "Heart-Healing" Experiences


BANGKOK, February 10, 2026
Simple Foods Co., Ltd., the manufacturer and distributor of 137 Degrees® premium plant-based milk, has teamed up with the beloved fan-favorite character Butterbear (Nong Noey) to host a festive Chinese New Year event: “Nong Noey Gives Luck, Gifting Lucky Ang Paos.” Held at Paragon Fashion Hall, 1st Floor, Siam Paragon, the event featured a warm, smile-filled atmosphere designed to "heal the hearts" of the Butterbear "Mum-mee" fan community and the 137 Degrees family.


The event was held under the concept of sharing good fortune, health, and positive energy for the New Year. It seamlessly blended the core identity of 137 Degrees®—which prioritizes high-quality ingredients and nutritional value—with the bright, friendly, and approachable charm of Butterbear. The goal was to create more than just an event, but a cherished collective memory for all attendees and lucky fans.


Throughout the day, "Mum-mees," "Pop-mees," and Butterbear fans enjoyed a variety of interactive activities. These included fun zones designed to boost "luck and vibes" for the New Year, dedicated photo corners with Butterbear, and a tasting station featuring 137 Degrees®’ most popular flavors. This showcase reflected the brand’s commitment to healthy living through premium nut and grain milks that are both delicious and perfectly suited for modern lifestyles.

The major highlight was the appearance of Butterbear, featuring a Chinese singing show and on-stage activities that brought immense joy and energy to the crowd. This was followed by interactive sessions where lucky fans were given the opportunity to engage closely with the character.


For the Top Spenders, the rewards were truly "heart-full," including stage privileges, exclusive gifts from 137 Degrees®, and a private 1-on-1 photo session with Butterbear. Meanwhile, Lucky Fans among the "Mum-mees" and "Pop-mees" participated in group activities and photo sessions. The atmosphere was intimate, reinforcing 137 Degrees®’ image as a brand that offers more than just health products, but also values deep consumer relationships and positive experiences.


137 Degrees® showcased its full range of nut milks, including Almond, Walnut, Pistachio, Macadamia, and Chocolate blends. All products are made from premium ingredients with no added cane sugar, zero trans-fats, and no cholesterol—catering to health-conscious individuals, those with lactose intolerance, and the elderly.


The “Nong Noey Gives Luck, Gifting Lucky Ang Paos” event was a perfect fusion of fun, warmth, and wellness. It reaffirmed 137 Degrees®’ position as the no.1 bestseller plant-based milk in Thailand, as well as a brand dedicated to building a lasting bond with consumers during every important milestone. For more news, activities, and product information, follow 137 Degrees® Almond Milk on Facebook: 137 Degrees.


Monday, January 19, 2026

Novo Nordisk Thailand rolls out blockchain-based digital solution to authenticate weight-loss medication, tackle counterfeit products and boost patient safety

Cihan Serdar Kizilcik
Following the article by the Thai Food and Drug Administration (FDA) regarding the counterfeit products of GLP-1RA on online platforms[i], Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”) launched eZTracker, a blockchain-enabled traceability system that verifies the authenticity of the company’s once‑weekly weight‑loss medicine, Wegovy®, across the supply chain. This innovative solution uses a unique 2D data matrix sticker to make every pack individually identifiable and traceable, aiming to proactively prevent counterfeit medicines and strengthen product safety for people with obesity.

Counterfeit products can contain incorrect doses of ingredients or even harmful substances, which may cause serious adverse effects. Unauthorised parallel imports, where products are brought into the country through unofficial distribution channels without manufacturer authorisation, can also bypass quality and safety controls, increasing the risk of substandard or tampered medicines. Together, these issues expose patients to the dangers of ineffective and harmful treatments.

Cihan Serdar Kizilcik, General Manager of Novo Nordisk Pharma (Thailand) Ltd., said: “Patient safety is Novo Nordisk’s highest priority. We have already implemented the eZTracker solution for two of our company’s once-weekly injectable products. We introduced this digital verification system in 2025, first on our type 2 diabetes treatment product Ozempic®, and now for our obesity treatment Wegovy®. In doing so, we have raised the bar for product authentication and observed a significant reduction in counterfeit incidents reported. eZTracker effectively helps protect patients by detecting counterfeit products and reinforces our commitment to the highest standards of product safety.”

Healthcare professionals, pharmacists and patients can verify the authenticity of this Novo Nordisk’s product in real time by scanning the pink 2D QR sticker on the box or by entering the product code in the eZTracker app. A successful check will confirm that the product is genuine and display detailed product information. If verification fails, the item is likely counterfeit. Users are encouraged to report unsuccessful scans through the eZTracker app to support efforts against counterfeit products and help keep patients safe.

About Novo Nordisk: 
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 78,500 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.

[i] https://www.fda.moph.go.th/news/news802569/